|
|
TTD Drug ID:
DAP100399
Drug
Information |
Name | Doxycycline | Synonyms | Vibramycin Novum; Spectrum2_000143; DivK1c_000345; CHEBI:50845; NSC633557; Doxycycline (INN); 6-Deoxyoxytetracycline; Doxycyclin; AC1O8PYM; alpha-Doxycycline; 94088-85-4 (calcium salt (1:2)); 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)-; 7264-10-0; DOXYCYCLINE MONOHYDRATE; Hydramycin; Doxitard; Doxycyclinum; KBioGR_001133; SMP1_000107; Lopac0_000405; doxycycline; LS-187766; Supracyclin; BCBcMAP01_000024; AC1NQXW7; CID5463943; Doxivetin; Doxycycline (200mg/day) or Placebo; SPBio_002784; Doxycycline hyclate; Monodox; Spectrum5_000947; Doxiciclina; KBio2_003855; Apo-Doxy; 24390-14-5; HMS2090E06; BSPBio_001936; Vibramycin; Doxy-Puren; Doxytec; DB00254; Prestwick3_000852; Liviatin; Prestwick2_000852; NCGC00179395-01; CID5281011; DOXCYCLINE ANHYDROUS; Doxytetracycline; (2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; Doxycycline (anhydrous); 6-Deoxytetracycline; 6alpha-Deoxy-5-oxytetracycline; Azudoxat; Vibravenos; DOXYCYCLINE CALCIUM; BMY-28689; NINDS_000345; Prestwick0_000852; Doxychel (TN); 69935-17-7 (mono-hydrochloride, di-hydrate); NCGC00161602-01; Doxiciclina [INN-Spanish]; (2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; Vivox (*Hyclate); EINECS 209-271-1; KBio1_000345; LS-93868; 564-25-0; 7164-70-7; DMSC (*Fosfatex); Spectrum_000807; KBio2_001287; HSDB 3071; Oracea; Doxychel; 6-alpha-Deoxy-5-oxytetracycline; Doxycycline anhydrous; (2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; Doxysol; CID6713981; Jenacyclin; UPCMLD-DP021:001; BIDD:GT0146; Novo-Doxylin; C06973; Doxy-Caps; Deoxymykoin; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS); Doxycen; Ronaxan; STOCK1N-34341; alpha-6-Deoxyoxytetracycline; BU-3839T; 5-Hydroxy-alpha-6-deoxytetracycline; Alti-Doxycycline; Doxycycline (internal use); Vibra-tabs; NCGC00167961-01; 10597-92-9; NCGC00161602-03; CID5353597; IDI1_000345; GS-3065 (*monohydrate); KBio2_006423; BSPBio_000863; alpha-6-Deoxy-5-hydroxytetracycline; Doxycyclinum [INN-Latin]; Spectrum3_000408; Dossiciclina [DCIT]; BPBio1_000951; Doxycin; Doxiciclina [Italian]; Vibramycine; KBioSS_001287; Doxycycline-Chinoin; 2-Naphthacenecarboxamide, 4-alpha-S-(dimethylamino)-1,4,4a-alpha-5,5a-alpha,6,11,12a-octahydro-3,5-alpha,10,12,12a-alpha-pentahydroxy-6-alpha-methyl-1,11-dioxo-; SPBio_000246; Vibramycin (*monohydrate); AB08 (*Fosfatex); Dossiciclina; KBio3_001156; CHEMBL1433; Investin; Oxytetracycline, 6-deoxy-; UPCMLD-DP021; MolPort-002-507-423; D07876; Doxycycline (TN); Prestwick1_000852; 41411-66-9 (6-epimer, mono-hydrochloride); Atridox; AC1NS4CW; Doxy-Tabs; AC1NUYS8; CPD001550033; DOXY; UNII-334895S862; NCGC00161602-04; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha))-; (2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; Monodox (*monohydrate); (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide; 17086-28-1 (mono-hydrate); Spectrum4_000527; Spanor; SAM002589932; Nu-Doxycycline | Trade Name | Periostat | Company | Collagenex | Indication | Advanced gum disease, chronic periodontitis [ICD9: 523.4, 523.5 ICD10: K05.3, K05.4] | Approved [1] | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format
| Therapeutic Class | Antiinflammatory | CAS Number | CAS 564-25-0 | Formula | C22H24N2O8 | PubChem Compound ID | CID 5281011. | PubChem Substance ID | SID 9187. | ChEBI | 50845; | SuperDrug ATC ID | A01AB22; J01AA02 | SuperDrug CAS ID | 000564250; | Target | MMP-8 |  | Inhibitor | [2][3][4] | Ref 1 | How many modes of action should an antibiotic have? Curr Opin Pharmacol. 2008 Oct;8(5):564-73. Epub 2008 Jul 30. To Reference | Ref 2 | 16498445 | Ref 3 | 17199549 | Ref 4 | 20370419 |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|